Arrowhead Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 75 U.S.-traded ETFs. ARWR has around 18.1M shares in the U.S. ETF market. The largest ETF holder of ARWR is the iShares Core S&P Small-Cap ETF (IJR), with approximately 5.85M shares. Investors may also find of interest that the ETF with the largest allocation to ARWR stock is Invesco S&P SmallCap Health Care ETF (PSCH), with a portfolio weight of 6.16%. On average, U.S. ETFs allocate 0.87% of ARWR to their portfolios.
Additionally, ARWR is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ARWR as a holding is the Invesco DWA NASDAQ Momentum ETF (DWAQ), with a return of 17.61%.